Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Hutter

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Cancers|August 27, 2021
Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AMLAnna Wojtuszkiewicz, Inge van der Werf, Stephan Hutter, et al.
Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.
Blood Advances|October 24, 2023
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencingAnna Maierhofer, Nikita Mehta, Ryan A Chisholm, et al.
Leukemia|November 30, 2021
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasiaSunisa Kongkiatkamon, Simona Pagliuca, Vera Adema, et al.
Blood Advances|August 27, 2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classificationInge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Leukemia|May 18, 2021
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Leukemia|July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Blood|December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Leukemia|April 24, 2026
Prevalence and characterization of germline RAS pathway variants in children with chronic myeloid leukemiaTabita Ghete, Laura Gaschler, Manuela Krumbholz, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cancers|August 27, 2021
Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AMLAnna Wojtuszkiewicz, Inge van der Werf, Stephan Hutter, et al.
Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.
Blood Advances|October 24, 2023
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencingAnna Maierhofer, Nikita Mehta, Ryan A Chisholm, et al.
Leukemia|November 30, 2021
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasiaSunisa Kongkiatkamon, Simona Pagliuca, Vera Adema, et al.
Blood Advances|August 27, 2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classificationInge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Leukemia|May 18, 2021
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Leukemia|July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Blood|December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Leukemia|April 24, 2026
Prevalence and characterization of germline RAS pathway variants in children with chronic myeloid leukemiaTabita Ghete, Laura Gaschler, Manuela Krumbholz, et al.
Pageof 8